BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 12894525)

  • 21. Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas.
    Saqi A; Yun SS; Yu GH; Alexis D; Taub RN; Powell CA; Borczuk AC
    Diagn Cytopathol; 2005 Aug; 33(2):65-70. PubMed ID: 16007640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the cell-surface heparan sulfate proteoglycan mRNA in monkey submandibular gland.
    Yamagata E; Kamada A
    J Osaka Dent Univ; 1999 Oct; 33(2):83-7. PubMed ID: 10863479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine regulation of syndecan expression in cells of liver origin.
    Sebestyén A; Gallai M; Knittel T; Ambrust T; Ramadori G; Kovalszky I
    Cytokine; 2000 Oct; 12(10):1557-60. PubMed ID: 11023673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The activation and composition of FiRE (an FGF-inducible response element) differ in a cell type- and growth factor-specific manner.
    Jaakkola P; Määttä A; Jalkanen M
    Oncogene; 1998 Sep; 17(10):1279-86. PubMed ID: 9771971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
    Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Syndecans in cell adhesion and differentiation].
    Brzóska E; Grabowska I
    Postepy Biochem; 2005; 51(1):52-9. PubMed ID: 16209342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of syndecan-1 changes during the differentiation of visceral and parietal endoderm from murine F9 teratocarcinoma cells.
    Jiang R; Kato M; Bernfield M; Grabel LB
    Differentiation; 1995 Nov; 59(4):225-33. PubMed ID: 8575644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
    Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
    Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
    Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
    Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of 9 genes, including that for thioredoxin, during epithelial differentiation of mesothelioma cells.
    Sun X; Dobra K; Björnstedt M; Hjerpe A
    Differentiation; 2000 Dec; 66(4-5):181-8. PubMed ID: 11269944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
    Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
    Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syndecan-1 in B lymphoid malignancies.
    Sanderson RD; Børset M
    Ann Hematol; 2002 Mar; 81(3):125-35. PubMed ID: 11904737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of syndecan in transformed mouse keratinocytes.
    Inki P; Gomez M; Quintanilla M; Cano A; Jalkanen M
    Lab Invest; 1992 Aug; 67(2):225-33. PubMed ID: 1501448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 polyunsaturated fatty acids regulate syndecan-1 expression in human breast cancer cells.
    Sun H; Berquin IM; Edwards IJ
    Cancer Res; 2005 May; 65(10):4442-7. PubMed ID: 15899837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of syndecan-1 in human gastric mucosa associated with ulceration.
    Tanabe H; Yokota K; Kohgo Y
    J Pathol; 1999 Feb; 187(3):338-44. PubMed ID: 10398089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes.
    Inki P; Larjava H; Haapasalmi K; Miettinen HM; Grenman R; Jalkanen M
    Eur J Cell Biol; 1994 Feb; 63(1):43-51. PubMed ID: 8005104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation.
    Casar JC; Cabello-Verrugio C; Olguin H; Aldunate R; Inestrosa NC; Brandan E
    J Cell Sci; 2004 Jan; 117(Pt 1):73-84. PubMed ID: 14627628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of proteoglycan core proteins in human bone marrow stroma.
    Schofield KP; Gallagher JT; David G
    Biochem J; 1999 Nov; 343 Pt 3(Pt 3):663-8. PubMed ID: 10527946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anders Jahre Prize for young researchers 1993. Syndecan--a regulator of growth factor activities between cells and cell matrix interface].
    Jalkanen M
    Nord Med; 1994; 109(3):72-3. PubMed ID: 7511221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
    Chen CL; Ou DL
    Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.